HM15275
Phase 1- Indications
- Obesity, Type 2 diabetes mellitus, Cardiovascular disease
Company intelligence / Profile preview
Hanmi Fine Chemical operates at commercial scale with global regulatory approvals. It supplies APIs to over forty countries and has passed US FDA inspections for sterile raw materials. The company recently expanded into high-tech CDMO work including synthesis of mRNA vaccine ingredients. Its cephalosporin products are recognized in major markets such as the US and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hanmi Fine Chemical.